Evidence map›Paper›PMID 27479529›Full record

ArticleProtein science : a publication of the Protein Society2016

Characterization of low affinity Fcγ receptor biotinylation under controlled reaction conditions by mass spectrometry and ligand binding analysis.

Karin P M Geuijen, David F Egging, Stefanie Bartels, Jan Schouten, Richard B Schasfoort, Michel H Eppink

Open access · bronzeAbstract read
In one paragraph

Article in Protein science : a publication of the Protein Society, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Karin P M GeuijenDownstream Processing, Synthon Biopharmaceuticals, BV, 6503, GN Nijmegen, The Netherlands. karin.geuijen@synthon.com.ORCID 0000-0003-2952-170X
David F EggingPreclinical Department, Synthon Biopharmaceuticals, BV, 6503, GN Nijmegen, The Netherlands.
Stefanie BartelsUpstream Processing, Synthon Biopharmaceuticals, BV, 6503, GN Nijmegen, The Netherlands.
Jan SchoutenUpstream Processing, Synthon Biopharmaceuticals, BV, 6503, GN Nijmegen, The Netherlands.
Richard B SchasfoortMedical Cell Biophysics group, MIRA institute, Faculty of Science and Technology, University of Twente, 7500 AE, Enschede, The Netherlands.
Michel H EppinkDownstream Processing, Synthon Biopharmaceuticals, BV, 6503, GN Nijmegen, The Netherlands.
Synthon (Netherlands) · NLUniversity of Twente · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chemical protein biotinylation and streptavidin or anti-biotin-based capture is regularly used for proteins as a more controlled alternative to direct coupling of the protein on a biosensor surface. On biotinylation an interaction site of interest may be blocked by the biotin groups, diminishing apparent activity of the protein. Minimal biotinylation can circumvent the loss of apparent activity, but still a binding site of interest can be blocked when labeling an amino acid involved in the binding. Here, we describe reaction condition optimization studies for minimal labeling. We have chosen low affinity Fcγ receptors as model compounds as these proteins contain many lysines in their active binding site and as such provide an interesting system for a minimal labeling approach. We were able to identify the most critical parameters (protein:biotin ratio and incubation pH) for a minimal labeling approach in which the proteins of choice remain most active toward analyte binding. Localization of biotinylation by mass spectrometric peptide mapping on minimally labeled material was correlated to protein activity in binding assays. We show that only aiming at minimal labeling is not sufficient to maintain an active protein. Careful fine-tuning of critical parameters is important to reduce biotinylation in a protein binding site.

Indexed as

Mass SpectrometrySurface Plasmon ResonanceBiotinylationHydrogen-Ion ConcentrationLigandsPeptidesReceptors, IgGFCGR3A protein, humanLigandsPeptidesReceptors, IgGFcγ receptorligand bindingminimal labelingoriented immobilizationprotein-protein interactions

Identifiers

PMID27479529
PMCPMC5029539
OpenAlexW2489064421

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.